ALP fermenter retrofit (pharma)
Basic and detailed design for a fermenter retrofit in a pharmaceutical plant.
Request a proposal by e-mail
Project summary
| Sector | Pharma & biotech | Company | Novo Nordisk |
|---|---|---|---|
| Location | Montes Claros – MG | Approximate investment | US$ 30 million |
| Project no. | OS 037 | Scope |
|
The main challenge
Engecell worked on the basic and detailed design.
The fermentation was reworked without invasive changes to the main equipment, making the process more stable and less prone to contamination. The technology was preserved, keeping the worldwide production strategy for the stages of the process that makes insulin for human use.
Key success indicators
| The design was audited and defended in a workshop with the contractor and the end client |
| The end client involved its production, engineering and research teams and approved the final design with few comments |
Engecell's challenges
| Using 3D software more competitive than the ones used on large greenfield projects |
| Meeting every pharmaceutical requirement |
